Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.2M
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
36.7M
-
Shares change
-
+2.79M
-
Total reported value, excl. options
-
$199M
-
Value change
-
+$12.5M
-
Put/Call ratio
-
0.15
-
Number of buys
-
59
-
Number of sells
-
-46
-
Price
-
$5.43
Significant Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q2 2022
130 filings reported holding CRBU - Caribou Biosciences, Inc. - Common Stock as of Q2 2022.
Caribou Biosciences, Inc. - Common Stock (CRBU) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.7M shares
of 92.2M outstanding shares and own 39.78% of the company stock.
Largest 10 shareholders include PFM Health Sciences, LP (6M shares), BlackRock Inc. (4.05M shares), Avidity Partners Management LP (2.95M shares), PICTET ASSET MANAGEMENT SA (2.69M shares), FARALLON CAPITAL MANAGEMENT LLC (2.2M shares), VANGUARD GROUP INC (1.99M shares), Rokos Capital Management LLP (1.91M shares), FMR LLC (1.52M shares), Assenagon Asset Management S.A. (1.11M shares), and ALKEON CAPITAL MANAGEMENT LLC (874K shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.